These factors promoted glycolysis in tumor cells, leading to enhanced lactate synthesis and secretion.[49, 52] In lung adenocarcinoma, KRAS mutations frequently cooccur with loss‐of‐function mutations in the LKB1 gene. This evidence concerns the gene KRAS and neoplasm.